
Lumexa Imaging Holdings Inc has a consensus price target of $22.67 based on the ratings of 7 analysts. The high is $23 issued by Raymond James on January 5, 2026. The low is $22 issued by Wells Fargo on January 5, 2026. The 3 most-recent analyst ratings were released by Raymond James, Barclays, and Wells Fargo on January 5, 2026, respectively. With an average price target of $22.67 between Raymond James, Barclays, and Wells Fargo, there's an implied 36.55% upside for Lumexa Imaging Holdings Inc from these most-recent analyst ratings.
1calculated from analyst ratings
| Get Alert | |||||
|---|---|---|---|---|---|
| Jan 5, 2026 | 38.55% | 23 | Previous Initiates Current Outperform | Get Alert | |
| Jan 5, 2026 | 38.55% | — | 23 | Previous Initiates Current Overweight | Get Alert |
| Jan 5, 2026 | 32.53% | — | 22 | Previous Initiates Current Overweight | Get Alert |
| Jan 5, 2026 | — | — | Previous Initiates Current Outperform | Get Alert | |
| Jan 5, 2026 | 32.53% | 22 | Previous Initiates Current Buy | Get Alert | |
| Jan 5, 2026 | 38.55% | — | 23 | Previous Initiates Current Outperform | Get Alert |
| Jan 5, 2026 | 38.55% | 23 | Previous Initiates Current Buy | Get Alert |
The latest price target for Lumexa Imaging Holdings (NASDAQ:LMRI) was reported by Raymond James on January 5, 2026. The analyst firm set a price target for $23.00 expecting LMRI to rise to within 12 months (a possible 38.55% upside). 7 analyst firms have reported ratings in the last year.
The latest analyst rating for Lumexa Imaging Holdings (NASDAQ:LMRI) was provided by Raymond James, and Lumexa Imaging Holdings initiated their outperform rating.
There is no last upgrade for Lumexa Imaging Holdings
There is no last downgrade for Lumexa Imaging Holdings.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Lumexa Imaging Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Lumexa Imaging Holdings was filed on January 5, 2026 so you should expect the next rating to be made available sometime around January 5, 2027.
While ratings are subjective and will change, the latest Lumexa Imaging Holdings (LMRI) rating was a initiated with a price target of $0.00 to $23.00. The current price Lumexa Imaging Holdings (LMRI) is trading at is $16.60, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.